HiberCell
Biotechnology Research · New York, New York, United States · 29 Employees
Who is HiberCell
HiberCell is a clinical stage oncology company, dedicated to the advancement of first-in-class agents with the novel MOA of modulation of adaptive stress pathways and anti-tumor immunity. We believe that therapeutic modulation of these mechanisms allows us to address tumor metastasis, treatment resistance, and cancer relapse; all significant drivers of cancer-related deaths. Our product candidates HC-5404 and HC-7366, both completing Phase 1a clinical trials, target the stress response kinases PERK and GCN2, respectively, while our product candidate odetiglucan, currently in Phase 2 clinical development, modulates the anti-tumor innate immune response.
Company Information
Website
Industry
Employees
29
Address
Frequently Asked Questions regarding HiberCell
Where is HiberCell based?
HiberCell is based in New York, New York, United States.
What industry does HiberCell belong to?
HiberCell is in the industry of: Biotechnology Research
How many employees does HiberCell have?
29 peoples are employed at HiberCell
What is HiberCell's official website?
HiberCell official website is
https://www.hibercell.com/
What are HiberCell social media links?
HiberCell
LinkedIn
page